MCID: NPH003
MIFTS: 40

Nephrocalcinosis malady

Categories: Rare diseases, Metabolic diseases, Nephrological diseases

Aliases & Classifications for Nephrocalcinosis

About this section

Aliases & Descriptions for Nephrocalcinosis:

Name: Nephrocalcinosis 10 45 47 12 36 65
 
Hypercalcemic Nephropathy 45 65

Classifications:



External Ids:

Disease Ontology10 DOID:12679
MeSH36 D009397
NCIt42 C84918
UMLS65 C0027709, C0152023

Summaries for Nephrocalcinosis

About this section
NIH Rare Diseases:45 Nephrocalcinosis is a disorder in which there is excess calcium deposited in the kidneys. it is relatively common in premature infants. individuals may be asymptomatic or have symptoms related to the condition causing nephrocalcinosis. if kidney stones are present, an individual may have blood in the urine; fever and chills; nausea and vomiting; or severe pain in the belly area, sides of the back (flank), groin, or testicles. later symptoms related to nephrocalcinosis may be associated with chronic kidney failure. it may be caused by use of certain medications or supplements; infection; or any condition that leads to high levels of calcium in the blood or urine including hyperparathyroidism, renal tubular acidosis, alport syndrome, bartter syndrome, and a variety of other conditions. some of the underlying disorders that can cause nephrocalcinosis are genetic, with the inheritance pattern depending on the specific disorder. the goal of treatment is to reduce symptoms and prevent more calcium from being deposited in the kidneys. last updated: 2/24/2011

MalaCards based summary: Nephrocalcinosis, also known as hypercalcemic nephropathy, is related to nephrolithiasis, type i and allergic asthma. An important gene associated with Nephrocalcinosis is CLDN16 (Claudin 16), and among its related pathways are Glycine, serine and threonine metabolism and Glyoxylate metabolism and glycine degradation. Affiliated tissues include kidney, lung and bone, and related mouse phenotypes are skeleton and renal/urinary system.

Wikipedia:68 Nephrocalcinosis, once known as Albright\'s calcinosis after Fuller Albright, or \"Anderson-Carr\"... more...

Related Diseases for Nephrocalcinosis

About this section

Diseases related to Nephrocalcinosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 395)
idRelated DiseaseScoreTop Affiliating Genes
1nephrolithiasis, type i30.3CLCN5, CLCNKB, CLDN16, SLC12A1
2allergic asthma29.4CLCNKB, SLC12A1
3proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis12.5
4familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement12.3
5familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement12.3
6dent disease11.7
7hypomagnesemia 3, renal11.7
8amelogenesis imperfecta, type ig11.7
9amelogenesis imperfecta hypoplastic type, ig11.6
10hypomagnesemia 5, renal, with ocular involvement11.6
11blue diaper syndrome11.4
12hypomagnesemia primary11.4
13lubinsky syndrome11.2
14manz syndrome11.2
15hypergonadotropic hypogonadism-cataract syndrome11.2
16hypocalcemia, autosomal dominant10.4
17hypophosphatemic rickets10.4
18dent disease 210.4
19endotheliitis10.4
20sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay10.3
21short syndrome10.3
22hypomagnesemia 1, intestinal10.3
23renal tubular acidosis, distal, ar10.3
24hypercalcemia, infantile10.3
25neuronitis10.3
26sengers syndrome10.3ATP6V1B1, SLC4A1
27renal tubular acidosis, distal, type 310.2ATP6V1B1, SLC4A1
28breast cancer10.2
29renal tubular acidosis with deafness10.2
30hyperoxaluria, primary, type 110.2
31renal tubular acidosis, distal, autosomal recessive10.2
32hyperoxaluria, primary, type ii10.2
33bartter syndrome, type 210.2
34bartter syndrome, type 110.2
35apparent mineralocorticoid excess10.2
36renal tubular acidosis, distal, ad10.2
37hypocalcemia, autosomal dominant 210.2
38fanconi renotubular syndrome 4, with maturity-onset diabetes of the young10.2
39slc4a1-associated distal renal tubular acidosis10.2
40leukemia10.2
41lymphoma10.2
42prostatitis10.2
43cervicitis10.2
44retinitis10.2
45pancreatitis10.2
46hypoxia10.2
47long qt syndrome 1310.2KCNJ1, SLC12A1
48laubry-pezzi syndrome10.1KCNJ1, SLC12A1
49schizophrenia10.1
50arthritis10.1

Graphical network of the top 20 diseases related to Nephrocalcinosis:



Diseases related to nephrocalcinosis

Symptoms for Nephrocalcinosis

About this section

Drugs & Therapeutics for Nephrocalcinosis

About this section

Drugs for Nephrocalcinosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydrochlorothiazideapprovedPhase 2, Phase 338758-93-53639
Synonyms:
125727-50-6
3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi
3,4-Dihydrochlorothiazide
58-93-5
6-Chloro-7-sulfamoyl-3, 4-dihy
8049-49-8
AB00052012
AC-11072
AC1L1GDT
AC1Q55FM
AF-614/30832002
AKOS000121373
ARONIS24316
Acesistem
Acuilix
Acuretic
Aldactazide
Aldactazide 25/25
Aldazida
Aldectazide 50/50
Aldoril
Ambap58-93-5
Apo-Hydro
Apresazide
Aquarills
Aquarius
Aquazide H
Aquazide-H
BAS 00371709
BIDD:GT0153
BPBio1_000019
BRD-K13078532-001-05-2
BRN 0625101
BSPBio_000017
BSPBio_002132
Bio-0714
Bremil
Briazide
C7H8ClN3O4S2
CAS-58-93-5
CCRIS 2082
CHEMBL435
CID3639
CPD000035778
Caplaril
Capozide
Carozide
Catiazida
Chlorizide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Chlothia
Cidrex
Clorana
Component of Butizide Prestabs
Concor Plus
Condiuren
D00340
D006852
DB00999
Diaqua
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Didral
Dihydran
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Disothiazid
Diu 25 Vigt
Diu-Melusin
Diu-melusin
Diuril
Diurogen
DivK1c_000289
Dixidrasi
Drenol
Dyazide
EINECS 200-403-3
EU-0100614
Esidrex
Esidrix
Esidrix (TN)
Esimil
Esoidrina
FT-0082750
Fluvin
H 4759
H1274
H2910_SIAL
H4759_SIAL
HCT
HCT-Isis
HCTZ
HCZ
HMS1568A19
HMS1920D19
HMS2091L05
HMS500O11
HMS553N04
HSDB 3096
Hidril
Hidro-Niagrin
Hidrochlortiazid
Hidroclorotiazida
Hidroclorotiazida [INN-Spanish]
Hidroronol
Hidrosaluretil
Hidrotiazida
Hyclosid
Hydrex-semi
Hydril
Hydro Par
Hydro-Aquil
Hydro-D
Hydro-Diuril
Hydro-Saluric
Hydro-T
Hydro-chlor
HydroDIURIL
Hydrochlorat
Hydrochloro Thiazide
Hydrochlorot
Hydrochlorothiazid
Hydrochlorothiazide
Hydrochlorothiazide (JP15/USP/INN)
Hydrochlorothiazide Intensol
Hydrochlorothiazide [INN:BAN:JAN]
 
Hydrochlorothiazidum
Hydrochlorothiazidum [INN-Latin]
Hydrochlorthiazide
Hydrochlorthiazidum
Hydrocot
Hydrodiuretic
Hydrodiuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hydrozide Injection, Veterinary
Hypothiazid
Hypothiazide
Hytrid
Hyzaar
I09-0531
IDI1_000289
Idroclorotiazide
Idroclorotiazide [DCIT]
Idrotiazide
Inderide
Inderide 80/25
Indroclor
Ivaugan
Jen-Diril
KBio1_000289
KBio2_001357
KBio2_003925
KBio2_006493
KBio3_001352
KBioGR_000351
KBioSS_001357
LS-243
Lopac-H-4759
Lopac0_000614
Lopressor HCT
Lotensin HCT
Lotensin Hct
MLS000069619
Manuril
Maschitt
Maxzide
Maybridge Compound 10
Maybridge1_004336
Mazide 25 mg
Medozide
Megadiuril
Microzide
Microzide (TN)
Mictrin
Mikorten
Modurcen
Moduretic
MolPort-000-144-465
NCGC00015508-01
NCGC00015508-02
NCGC00015508-03
NCGC00015508-07
NCGC00015508-12
NCGC00021906-03
NCGC00021906-04
NCGC00021906-05
NCGC00021906-06
NCGC00021906-07
NCGC00021906-08
NCI-C55925
NCI60_004317
NINDS_000289
NSC 53477
NSC53477
Natrinax
Nefrix
Nefrol
Neo-Codema
Neo-Flumen
Neo-Minzil
Neo-codema
Neoflumen
Newtolide
Novodiurex
Oprea1_357174
Oretic
Pantemon
Panurin
Prestwick0_000009
Prestwick1_000009
Prestwick2_000009
Prestwick3_000009
Prestwick_263
Prinzide
Raunova Plus
Ro-Hydrazide
Ro-hydrazide
Roxane
S1708_Selleck
SAM002554901
SMR000035778
SPBio_001259
SPBio_001938
SPECTRUM1500335
STK315354
Saldiuril
Sectrazide
Selozide
Ser-Ap-Es
Servithiazid
Spectrum2_001040
Spectrum3_000456
Spectrum4_000006
Spectrum5_000824
Spectrum_000877
Spironazide
Su 5879
Tandiur
Thiaretic
Thiuretic
Thlaretic
Timolide
UNII-0J48LPH2TH
Unazid
Unipres
Urodiazin
Urozide
Vaseretic
Vetidrex
WLN: T66 BSWM EM DHJ HG ISZW
ZINC00896569
Ziac
Zide
adiazine-1,1-dioxide
component of Aldactazide
component of Aldoril
component of Caplaril
component of Cyclex
component of Dyazide
component of Esimil
diclot ride
dro-2H-1,2,4-benzothiadiazine 1,1-dioxide
hydrochlorothiazide
panurin dichloride
2AnticoagulantsPhase 31760
3Pharmaceutical SolutionsPhase 37004
4Calcium, DietaryPhase 3, Phase 2, Phase 14678
5Chelating AgentsPhase 3667
6Hormone AntagonistsPhase 2, Phase 310002
7EndorphinsPhase 2, Phase 347
8Bone Density Conservation AgentsPhase 2, Phase 32600
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 2, Phase 39988
10Neurotransmitter AgentsPhase 2, Phase 314795
11beta-endorphinPhase 2, Phase 399
12Melanocyte-Stimulating HormonesPhase 2, Phase 398
13HormonesPhase 2, Phase 311748
14ExpectorantsPhase 3337
15Adrenocorticotropic HormonePhase 2, Phase 3133
16Natriuretic AgentsPhase 3, Phase 21403
17diureticsPhase 3, Phase 21194
18Potassium CitratePhase 321
19Respiratory System AgentsPhase 33931
20Sodium Chloride Symporter InhibitorsPhase 2, Phase 3399
21Antihypertensive AgentsPhase 2, Phase 33618
22CitrateNutraceuticalPhase 31001
23
Citric AcidnutraceuticalPhase 3100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
24potassium phosphatePhase 1, Phase 210
25Phosphorus SupplementNutraceuticalPhase 1, Phase 23
26
Magnesium Sulfateapproved1547487-88-924083
Synonyms:
(C10-C16) Alkylalcohol sulfuric acid, magnesium salt
00627_FLUKA
10028-26-9
10034-99-8 (heptahydrate)
13143_RIEDEL
13143_SIAL
139939-75-6
18939-43-0
203726_ALDRICH
208094_SIAL
34276_FLUKA
34276_RIEDEL
38146_FLUKA
38146_RIEDEL
63126_FLUKA
63136_FLUKA
63136_SIAL
63139_FLUKA
63139_SIAL
68081-97-0
7487-88-9
AC1L2N76
AC1LAX36
AC1Q1U66
AI3-02029
Bitter salt
C10-C16 Alkyl alcohol sulfuric acid magnesium salt
CCRIS 8411
CHEBI:32599
CID24083
CPD0-2390
Caswell No. 534
D008278
DB00653
EINECS 231-298-2
EINECS 233-073-4
EINECS 242-691-3
EINECS 268-365-0
EPA Pesticide Chemical Code 050503
Epsom Sal
Epsom Salt
Epsom Salt Magnesium Sulfate
Epsom Salt Soaking Solution
Epsom salt
HSDB 664
Hair salt
Health Smart Natural Epsom Salt
Heptahydrate Magnesium Sulfate
Humco Epson Salt
Kieserite [as monohydrate]
LS-88605
M2643_SIGMA
M3409_SIGMA
 
M7506_SIAL
M8150_SIGMA
MAGNESIUM SULFATE
Magnesium Sulfate
Magnesium Sulfate In Plastic Container
Magnesium Sulfate, Heptahydrate
Magnesium Sulphate Hydrate
Magnesium bisulfate
Magnesium hydrogensulphate
Magnesium sulfate
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulfate dried
Magnesium sulfate heptahydrate
Magnesium sulfate hexahydrate
Magnesium sulfate in dextrose 5% in plastic container
Magnesium sulfate solution
Magnesium sulphate
Magnesium sulphate anhydrous
Magnesium sulphate dried
Magnesium sulphate heptahydrate
Magnesium(II) sulfate
Magnesium(ii) sulfate
Magnesiumsulfat
MgSO4
MolPort-003-925-000
Morton Natural Epsom Salt
NSC 146179
Natural Epsom Salt
OT-S
OT-S (drying agent)
Pepsom Flying P Epsom Salt
Pepsom Salt Peppermint
Royal Epsom Salt
SDA 15-062-07
Sal Angalis
Sal De sedlitz
Sal amarum
Sal anglicum
Sal catharticum
Sal seidlitense
Salts of england
Sel d'angleterre
Sulfate, Magnesium
Sulfuric acid magnesium salt
Sulfuric acid magnesium salt (1:1)
Sulfuric acid magnesium salt (VAN)
Sulfuric acid, C10-16 alkyl ester, magnesium salt
Sulfuric acid, magnesium salt
Sulfuric acid, magnesium salt (1:1)
Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts
Tomix OT
UNII-DE08037SAB
UNII-ML30MJ2U7I
magnesium(2+) ion sulfate
27Peripheral Nervous System Agents18510
28Tocolytic Agents561
29Central Nervous System Depressants10016
30calcium channel blockers1743
31Anesthetics7385
32Anti-Arrhythmia Agents2371
33Anticonvulsants2249
34Analgesics9358

Interventional clinical trials:

(show all 11)
idNameStatusNCT IDPhase
1Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm InfantsCompletedNCT00249951Phase 3
2Effects of PTH Replacement on Bone in HypoparathyroidismActive, not recruitingNCT00395538Phase 3
3Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme PrematureNot yet recruitingNCT01756547Phase 3
4ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot StudyNot yet recruitingNCT02155803Phase 2, Phase 3
5Dose-Dependent Effect of Thiazide in Dent's Disease HypercalciuriaTerminatedNCT00638482Phase 2, Phase 3
6Role Of Phosphorus And FGF 23 In Patients With Dent DiseaseRecruitingNCT02016235Phase 1, Phase 2
7Preterm Infants and NephrocalcinosisRecruitingNCT02438267
8Renal Tubular Acidosis in Incident Renal Transplant RecipientsRecruitingNCT01283880
9Randall's Plaque Study: Pathogenesis and Relationship to NephrolithiasisRecruitingNCT00169806
10Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill PatientsTerminatedNCT01426165
11International Registry for Primary HyperoxaluriaWithdrawnNCT00875823

Search NIH Clinical Center for Nephrocalcinosis


Cochrane evidence based reviews: nephrocalcinosis

Genetic Tests for Nephrocalcinosis

About this section

Anatomical Context for Nephrocalcinosis

About this section

MalaCards organs/tissues related to Nephrocalcinosis:

33
Kidney, Lung, Bone, Breast, Endothelial, Pituitary, Brain

Animal Models for Nephrocalcinosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Nephrocalcinosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053907.7ATP6V1B1, CASR, CLCN5, CYP24A1, SLC12A1, SLC34A1
2MP:00053675.6AGXT, ATP6V1B1, CASR, CLCN5, CLCNKB, CLDN16
3MP:00053765.3AGXT, ATP6V1B1, CASR, CLCN5, CLCNKB, CLDN16

Publications for Nephrocalcinosis

About this section

Articles related to Nephrocalcinosis:

(show top 50)    (show all 540)
idTitleAuthorsYear
1
Dental Follicle Cells Participate in Tooth Eruption via the RUNX2-MiR-31-SATB2 Loop. (25818585)
2015
2
A complication of xanthogranulomatous cholecystitis with Mirizzi syndrome. (26044215)
2015
3
Upregulation of pa89Akt by glial cell linea89derived neurotrophic factor ameliorates cell apoptosis in the hippocampus of rats with streptozotocina89induced diabetic encephalopathy. (26549420)
2015
4
CT of Hepatic Sarcoidosis: Small Nodular Lesions Simulating Metastatic Disease. (25908950)
2015
5
To the left-to the right: sustained ventricular bigeminy from the "right" ventricular outflow tract in a patient with dextrocardia. (24444481)
2014
6
Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. (25057126)
2014
7
Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers. (24244552)
2013
8
Comparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse model. (23586776)
2013
9
Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. (23400076)
2013
10
Misoprostol as a therapeutic option for trigeminal neuralgia in patients with multiple sclerosis. (22925476)
2012
11
Increased I9Np63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma. (21833468)
2011
12
A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with large but not small abdominal aortic aneurysm. (21571276)
2011
13
Investigating the mechanism of disease in the RP10 form of retinitis pigmentosa. (20238057)
2010
14
Coincidence detection and stress modulation of spike time-dependent long-term depression in the hippocampus. (20445048)
2010
15
Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension. (20695936)
2010
16
Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma. (19590186)
2009
17
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. (19652097)
2009
18
Identification of two novel aquaporin-2 mutations in a Thai girl with congenital nephrogenic diabetes insipidus. (18473191)
2008
19
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer. (19141401)
2008
20
Acute pancreatitis as the first presentation of Wegener's granulomatosis. (18469442)
2008
21
An elderly case of type 2 diabetes which developed in association with oral and esophageal candidiasis. (17409603)
2007
22
High resolution MRI in the detection of an intrathymic parathyroid adenoma. (16940365)
2006
23
The debate: a case for randomized controls in invasive aspergillosis. (17050456)
2006
24
Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. (15814630)
2005
25
Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease. (15754404)
2005
26
Risk factors for mortality in patients undergoing percutaneous endoscopic gastrostomy. (15202049)
2004
27
The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers. (14514353)
2004
28
Polymorphism insertion/deletion of apolipoprotein B gene: effect on lipid levels in obese patients]. (15047470)
2004
29
Immunity and immunosuppression in experimental visceral leishmaniasis. (15064826)
2004
30
Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells. (15467738)
2004
31
Brain specific proteins in serum: do they reliably reflect brain damage? (12412631)
2002
32
Primary intracranial atypical teratoid/rhabdoid tumor in a child: a case report. (12378033)
2002
33
Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases. (11217812)
2001
34
Junctional epidermolysis bullosa with pyloric stenosis. (11841649)
2001
35
Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. (11426073)
2001
36
Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. (11318794)
2001
37
Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation. (10720297)
2000
38
Power-frequency electromagnetic fields and the capacitative calcium entry system in SV40-transformed Swiss 3T3 cells. (10790295)
2000
39
Unusual presentation of congenital syphilis. (10945059)
2000
40
Involvement of the proximal C terminus of the AMPA receptor subunit GluR1 in dendritic sorting. (10807936)
2000
41
Branch retinal artery occlusion: angiographic demonstration of increased retinal blood flow after external carotid endarterectomy. (10088062)
1999
42
Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors. (10365121)
1999
43
Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). (9576949)
1998
44
Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. (9437203)
1997
45
The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. (9051751)
1996
46
Upper airway obstruction caused by group G streptococcal laryngitis. (7717474)
1995
47
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. (7737190)
1995
48
The Bartter-like syndrome in 2 twins]. (8255271)
1993
49
Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. (2110586)
1990
50
Effect of hyperprolactinemia induced by prolactinoma (MtT/F84) on the accessory sexual organs of male rat. (3570843)
1986

Variations for Nephrocalcinosis

About this section

Expression for genes affiliated with Nephrocalcinosis

About this section
Search GEO for disease gene expression data for Nephrocalcinosis.

Pathways for genes affiliated with Nephrocalcinosis

About this section

Pathways related to Nephrocalcinosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.7AGXT, GRHPR
2
Show member pathways
9.7AGXT, GRHPR
39.7AGXT, GRHPR
49.2CLCNKB, KCNJ1, SLC12A1
5
Show member pathways
9.0ATP6V1B1, CLCNKB, SLC4A1
6
Show member pathways
7.9ATP6V1B1, CLCN5, CLCNKB, SLC12A1, SLC34A1, SLC4A1

GO Terms for genes affiliated with Nephrocalcinosis

About this section

Biological processes related to Nephrocalcinosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1potassium ion transportGO:000681310.2KCNJ1, SLC12A1
2response to potassium ionGO:003586410.1KCNJ1, SLC34A1
3glyoxylate metabolic processGO:00464879.7AGXT, GRHPR
4transportGO:00068109.2CLCN5, CLCNKB, SLC12A1
5ion transmembrane transportGO:00342208.4ATP6V1B1, CLCN5, CLCNKB, SLC12A1
6transmembrane transportGO:00550858.1ATP6V1B1, CLCN5, CLCNKB, SLC12A1, SLC34A1, SLC4A1

Sources for Nephrocalcinosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet